Posts Tagged: Biologics


Biosimilars Causing A Stir In The U.S. Market, Are You Ready?   Barriers to biosimilar uptake in the U.S. temper optimistic predictions of accelerated biosimilars market growth.   Wondering why the opening of the U.S. market to biosimilars isn’t resulting in a collective cheer or groan from the biopharmaceuticals industry? Despite the FDA approval of… Read more »